Antibiotic efficacy varies based on the infection model and treatment regimen for Pseudomonas aeruginosa

Antibiotic discovery and preclinical testing are needed to combat the Pseudomonas aeruginosa health threat. Most frequently, antibiotic efficacy is tested in models of acute respiratory infection, with chronic pneumonia remaining largely unexplored. This approach generates serious concerns about the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cigana, Cristina, Ranucci, Serena, Rossi, Alice, De Fino, Ida, Melessike, Medede, Bragonzi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057181/
https://www.ncbi.nlm.nih.gov/pubmed/31624114
http://dx.doi.org/10.1183/13993003.02456-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057181/
https://www.ncbi.nlm.nih.gov/pubmed/31624114
http://dx.doi.org/10.1183/13993003.02456-2018

Ejemplares similares